Antianémique And NotIain C. Macdougall

List of bibliographic references

Number of relevant bibliographic references: 7.

Ident.	Authors (with country if any)	Title
001360	Jan-Christoph Galle [Allemagne] ; Kathleen Claes [Belgique] ; Istvan Kiss [Hongrie] ; Christopher G. Winearls [Royaume-Uni] ; Hans Herlitz [Suède] ; Alain Guerin [France] ; Salvatore Di Giulio [Italie] ; Michael G. Suranyi [Australie] ; Ian Bridges [Royaume-Uni] ; Janet Addison [Royaume-Uni] ; Mourad Farouk [Suisse]	An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study
001D01	Simon D. Roger [Australie] ; Francesco Locatelli [Italie] ; Rainer P. Woitas [Allemagne] ; Maurice Laville [France] ; Sheldon W. Tobe [Canada] ; Robert Provenzano [États-Unis] ; Thomas A. Golper [États-Unis] ; Prajej Ruangkanchanasetr [Thaïlande] ; HO YUNG LEE [Corée du Sud] ; Kwan-Dun Wu [Taïwan] ; Michal Nowicki [Pologne] ; Agnes Ladanyi [Hongrie] ; Alberto Martinez-Castelao [Espagne] ; Ulrich Beyer [Suisse] ; Frank C. Dougherty [Australie]	C.E.R.A. once every 4 weeks corrects anaemia and maintains haemoglobin in patients with chronic kidney disease not on dialysis
003131	Bernard Canaud [France] ; Giulio Mingardi [Italie] ; Johann Braun [Allemagne] ; Pedro Aljama [Espagne] ; Peter G. Kerr [Australie] ; Francesco Locatelli [Italie] ; Giuseppe Villa [Italie] ; Bruno Van Vlem [Belgique] ; Alan W. Mcmahon [Canada] ; Cécile Kerloëguen [Suisse] ; Ulrich Beyer [Suisse]	Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa : results from STRIATA, a randomized phase III study
003D83	Jérome Rossert [France, Canada, Australie, Autriche, États-Unis, Suisse] ; Adeera Levin ; Simon D. Roger ; Walter H. Hörl ; Bruno Fouqueray ; Cristiana Gassmann-Mayer ; Dieter Frei ; William M. Mcclellan	Pathogenesis and treatment of kidney disease and hypertension : Effect of early correction of anemia on the progression of CKD
004322	Katia Boven [États-Unis, France, Singapour, Australie] ; Scott Stryker ; John Knight ; Adrian Thomas ; Marc Van Regenmortel ; David M. Kemeny ; David Power ; Jerome Rossert ; Nicole Casadevall	The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes
005444	Jerome Rossert [France] ; William M. Mcclellan [États-Unis] ; Simon D. Roger [Australie] ; Dierik L. Verbeelen [Belgique]	Epoetin treatment: what are the arguments to expect a beneficial effect on renal disease progression?
005493	J. A. Rossert [France] ; W. M. Mcclellan [États-Unis] ; S. D. Roger [Australie] ; D. L. Verbeelen [Belgique] ; W. H. Hörl [Autriche]	Contribution of anaemia to progression of renal disease: a debate

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024